Gr. Sarantis stock: fair value
SAR.ATThe fair value of Gr. Sarantis under our model is $26.07, the price is 50% below.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $20.06 and expensive above $37.25 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $31.04 (cash-flow model) and $21.11 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 9.1%. At 10.1% the fair value would be $23.64, at 8.1% it would be $29.56.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (23.8).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 3.5%. Discounted at 9.1% (government bond yield 3.5% plus beta 0.8 times a risk premium of 7.1%); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $31.04 per share: free cash flow for the next ten years, each year discounted to today at 9.1%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 9.1%) |
|---|---|---|---|---|
| 2026 | $77.89M | extrapolated at 23.1% | 0.9164 | $71.38M |
| 2027 | $91.32M | extrapolated at 17.2% | 0.8398 | $76.69M |
| 2028 | $103.28M | extrapolated at 13.1% | 0.7696 | $79.48M |
| 2029 | $113.82M | extrapolated at 10.2% | 0.7052 | $80.27M |
| 2030 | $123.14M | extrapolated at 8.2% | 0.6462 | $79.58M |
| 2031 | $131.47M | extrapolated at 6.8% | 0.5922 | $77.86M |
| 2032 | $139.07M | extrapolated at 5.8% | 0.5427 | $75.47M |
| 2033 | $146.13M | extrapolated at 5.1% | 0.4973 | $72.67M |
| 2034 | $152.84M | extrapolated at 4.6% | 0.4557 | $69.66M |
| 2035 | $159.35M | extrapolated at 4.3% | 0.4176 | $66.55M |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $749.6M |
| Terminal value: cash flow 2035 × (1 + 3.5%) / (9.1% − 3.5%) | $2.91B |
| Present value of terminal value (× 0.4176) | $1.22B |
| Equity value (sum plus present value of terminal value) | $1.97B |
| Shares (diluted) | 63.32M |
| Value per share (equity value divided by shares) | $31.04 |
| Earnings per share, last twelve months | $0.89 |
| × 23.8 (industry P/E) | $21.11 |
| Fair value (average of both parts) | $26.07 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 21 Aug 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.